Allstate Corporation’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
Allstate Corporation's DFTX Position: Q3 2026 in Review
Allstate Corporation reduced its Definium Therapeutics (DFTX) stake by 66% in Q3 2026, selling an estimated $1.27M and leaving 15,580 shares worth $593K. The position accounts for 0.01% of the portfolio, ranked #767.
Allstate Corporation first reported a position in DFTX in Q1 2026 and has held it in 3 quarters since. The position peaked at $2.15M in Q2 2026. 354 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.
- Allstate Corporation held 15,580 shares of Definium Therapeutics worth $593K as of Q3 2026.
- Allstate Corporation sold 30,059 Definium Therapeutics shares in Q3 2026, an estimated $1.27M.
- Definium Therapeutics made up 0.01% of Allstate Corporation's portfolio in Q3 2026, its #767 holding.
- Allstate Corporation first reported a position in Definium Therapeutics in Q1 2026 and has held it in 3 quarters since.
- Allstate Corporation's Definium Therapeutics position peaked at $2.15M in Q2 2026.
- 354 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.
Based on Allstate Corporation's 13F filing for Q3 2026, filed 16 Nov 2026.